RESONANCE SPECIALTIES LTD.-$

Resonance Specialties Ltd has announced that its Board of Directors will convene on October 30, 2026. The primary agenda item is to consider and approve the unaudited financial results for the second quarter and half-year ended September 30, 2026. Concurrently, the company has confirmed that the trading window for its securities will remain closed from September 30, 2026, until 48 hours after the declaration of these financial results, as per SEBI (Prohibition of Insider Trading) Regulations, 2015.

Resonance Specialties Ltd has announced the closure of its trading window for dealing in securities. The window will be shut from the close of business hours on September 30, 2026, and will reopen 48 hours after the declaration of the company's unaudited financial results for the second quarter and half-year ended September 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent insider trading. The date of the board meeting to approve these financial results will be communicated separately.

Resonance Specialties Ltd has announced the Board's approval to acquire a manufacturing facility from Kaygee Laboratories Pvt Ltd for ₹29.98 crores on a slump sale basis. The facility, located in Mandideep, Madhya Pradesh, includes land, buildings, plant & machinery, and employees. This acquisition is considered a related party transaction and has been conducted at an arm's length basis, supported by an independent valuation. The rationale includes securing uninterrupted production, enhancing operational control, and eliminating outsourcing costs for chemical intermediates and APIs. The transaction is subject to shareholder approval.

Resonance Specialties Ltd announced that its Board of Directors has approved the unaudited financial results for the first quarter ended June 30, 2026. Additionally, the board approved the purchase of a manufacturing facility, including land, buildings, plant & machinery, and licenses, located in Mandideep, Madhya Pradesh, from Kaygee Laboratories Private Limited, a related party. The acquisition will be on a slump sale basis for a consideration of ₹29.98 crores, subject to shareholder approval. The transaction is considered a related party transaction and has been conducted at arm's length, supported by an independent valuation certificate. The rationale for the acquisition includes securing uninterrupted production, enhancing operational control and efficiency, and eliminating outsourcing costs for essential chemical intermediates and APIs.

Resonance Specialties Ltd announced the outcome of its Board Meeting held on August 4, 2026. The board approved the unaudited financial results for the first quarter ended June 30, 2026, along with the limited review report. Additionally, the company approved the purchase of a manufacturing facility, including land, buildings, plant, and machinery, located in Mandideep, Madhya Pradesh, from Kaygee Laboratories Private Limited, a related party. The acquisition is on a slump sale basis for a consideration of ₹29.98 crores and is subject to shareholder approval. The manufacturing unit was originally set up by a former promoter group company and has been supplying chemical intermediates and APIs to Resonance Specialties on a job work basis. The acquisition aims to secure uninterrupted production, enhance operational control, and reduce outsourcing costs.

Resonance Specialties Ltd has announced that its Board of Directors will convene on August 4, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. In line with SEBI regulations, the trading window for company insiders will remain closed from June 30, 2026, until 48 hours after the financial results are declared. This meeting is a routine procedural step for the company to fulfill its financial reporting obligations.

Resonance Specialties Ltd has announced its 37th Annual General Meeting (AGM) will be held on Tuesday, August 4, 2026, at 12:30 p.m. IST via Video Conferencing/Other Audio-Visual Means. In compliance with SEBI regulations, the company has informed shareholders without registered email addresses about accessing the Annual Report for FY 2025-26 via a web-link on the company's website. The cut-off date for determining voting eligibility for the AGM is July 28, 2026. The company encourages shareholders to update their email IDs and consider dematerializing physical shareholdings.

Resonance Specialties Ltd announced its 37th Annual General Meeting (AGM) scheduled for August 4, 2026, to be held via video conference. The company is submitting its Annual Report for FY 2025-26, which includes audited financial statements, the Board's report, and the Auditors' report. Key agenda items include the adoption of financial statements, re-appointment of a director, declaration of dividend, and re-appointment of statutory auditors, Kailash Chand Jain & Co. The meeting will also seek approval for related party transactions. The Annual Report is available on the company's website and being sent electronically to shareholders.

Resonance Specialties Ltd announced its 37th Annual General Meeting (AGM) will be held on August 4, 2026, at 12:30 PM via Video Conferencing/Other Audio Visual Means (VC/OAVM). The company has fixed July 28, 2026, as the record date for determining shareholder entitlement to a proposed dividend of Re. 1/- per share (10%) for the financial year 2025-26. The Annual Report for FY2025-26, including the AGM notice, has been disseminated electronically to shareholders. The company also offers remote e-voting from July 31, 2026, to August 3, 2026, facilitated by NSDL.

Resonance Specialties Ltd has announced July 28, 2026, as the record date for determining shareholder entitlement to a dividend of Re. 1/- per share (10%). This dividend, if sanctioned at the upcoming Annual General Meeting (AGM), will be paid on or before August 28, 2026. The company has fixed this record date in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The face value of each share is Rs. 10/-.